Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) — Cash Flow Quality Index
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Cash Flow Quality Index of 0.90x as of December 2024. Operating cash flow of CN¥24.04 Million is below net income of CN¥26.57 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Hunan Dajiaweikang Pharmaceutical Indust balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Hunan Dajiaweikang Pharmaceutical Indust (301126) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2024)
Year-by-year earnings quality comparison for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. For live market cap and the full company financial profile, see market cap of Hunan Dajiaweikang Pharmaceutical Indust.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.90x | CN¥24.04 Million | CN¥26.57 Million | ▲ +14.4% |
| 2023 | 0.79x | CN¥27.13 Million | CN¥34.30 Million | ▲ +108.2% |
| 2022 | -9.66x | CN¥-493.96 Million | CN¥51.12 Million | ▼ -307.6% |
| 2021 | -2.37x | CN¥-161.81 Million | CN¥68.26 Million | ▼ -1.5% |
| 2020 | -2.34x | CN¥-151.46 Million | CN¥64.85 Million | ▼ -250.6% |
| 2019 | 1.55x | CN¥135.91 Million | CN¥87.65 Million | — |